Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.22 | 6e-10 |
mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.19 | 7e-09 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-08 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-08 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |